Neuroone Medical Technologies Corp (NASDAQ:NMTC)

Delayed Data
As of Oct 04
 +0.07 / +4.43%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Neuroone Medical Technologies Corp have a median target of 2.63, with a high estimate of 3.25 and a low estimate of 2.00. The median estimate represents a +56.25% increase from the last price of 1.68.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Neuroone Medical Technologies Corp. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Dec 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 35.29%
Growthannually 30.11%


Growthquarterly --
Growthannually 850.00%
Key to the earnings and sales forecast charts.